Transcriptomics

Dataset Information

0

Artemisinins target GABAA receptor signaling and impair alpha cell identity


ABSTRACT: Type 1 diabetes is characterized by the destruction of pancrea tic beta cells, and generating new insulin-producing cells from other cell types is a major aim of regenerative medicine. One promising approach is transdifferentiation of developmentally related pancreatic cell types including glucagon-producing alpha cells. In a genetic model, loss of the master regulatory transcription factor Arx is sufficient to induce the conversion of alpha cells to functional beta-like cells. Here we identify artemisinins as small molecules that functionally repress Arx by causing its translocation to the cytoplasm. We show that the protein gephyrin is the mammalian target of these antimalaria drugs, and that enhancement of GABAA receptor signaling contributes to the mechanism of action of these molecules in pancreatic transdifferentiation. Our results in zebrafish, rodents and primary human pancreatic islets indicate that gephyrin is a novel druggable target for the regeneration of pancreatic beta cell mass from alpha cells.

ORGANISM(S): Mus musculus

PROVIDER: GSE84592 | GEO | 2016/12/15

SECONDARY ACCESSION(S): PRJNA330538

REPOSITORIES: GEO

Similar Datasets

2017-01-19 | GSE84714 | GEO
2017-02-16 | GSE79457 | GEO
| PRJNA330917 | ENA
| PRJNA316075 | ENA
2021-09-09 | GSE183568 | GEO
2022-01-29 | GSE163947 | GEO
2022-01-29 | GSE178726 | GEO
2008-12-31 | E-GEOD-13381 | biostudies-arrayexpress
2023-04-10 | GSE224572 | GEO
| phs001910 | dbGaP